首页> 外文期刊>European review for medical and pharmacological sciences. >LncRNA DCST1-AS1 regulated cell proliferation, migration, invasion and apoptosis in gastric cancer by targeting miR-605-3p
【24h】

LncRNA DCST1-AS1 regulated cell proliferation, migration, invasion and apoptosis in gastric cancer by targeting miR-605-3p

机译:LNCRNA DCST1-AS1通过靶向MIR-605-3P患者胃癌中的调节细胞增殖,迁移,侵袭和细胞凋亡

获取原文
           

摘要

OBJECTIVE: Gastric cancer (GC) is one of the most common cancers in the world, with a high incidence and a poor prognosis. A large number of lncRNAs have been demonstrated to play multiple important roles in cancer development and progression. LncRNA is usually used as ceRNA and forms a regulatory network with miRNA in gastric cancer. However, the function and regulatory network of lncRNA in gastric cancer have not been fully elucidated. MATERIALS AND METHODS: The qRT-PCR assay was used to detect DCST1-AS1 and miR-605-3p expression. Western blot was applied to measure the protein expression of CDK4, cyclin D1, MMP-2, MMP-9, cleaved caspase 3, Bcl-2, Bax and β-actin. MTT assay and flow cytometry were performed to assess cell proliferation and apoptosis, respectively. Transwell migration and invasion assay were used to determine cell migration capacity and invasion ability. Luciferase reporter assay was applied to determine the relationship of DCST-AS1 and miR-605-3p in GC. RESULTS: In this study, we found that DCST1-AS1 was highly expressed while miR-605-3p was low expressed in GC tissues and cells. Moreover, DCST1-AS1 expression negatively regulated miR-605-3p expression in GC. Functionally test demonstrated that knockdown of DCST1 inhibited cell proliferation, migration and invasion as well as promoted cell apoptosis in GC cells. Interestingly, miR-605-3p has been verified to be a target miRNA of DCST1-AS1 with luciferase reporter assay. More than that, the reverse experiment determined that the inhibition of miR-605-3p could alleviate the suppressive effects of low DCST1-AS1 expression on cell growth in GC. CONCLUSIONS: We proved the regulatory network of lncRNA DCST1-AS1 for the first time, and also explored and found that lncRNA DCST1-AS1 regulated cell proliferation, migration, invasion and apoptosis by regulation of miR-605-3p, providing a new therapeutic target for gastric cancer treatment.
机译:目的:胃癌(GC)是世界上最常见的癌症之一,发病率高,预后差。已经证明了大量的LNCRNA在癌症发展和进展中发挥多重重要作用。 LNCRNA通常用作Cerna,并形成胃癌中miRNA的调节网络。然而,胃癌中LNCRNA的功能和调节网络尚未完全阐明。材料和方法:QRT-PCR测定用于检测DCST1-AS1和miR-605-3P表达。施用蛋白质印迹测量CDK4,细胞周期蛋白D1,MMP-2,MMP-9,切割的胱天蛋白3,BCL-2,BAX和β-肌动蛋白的蛋白质表达。进行MTT测定和流式细胞术以分别评估细胞增殖和细胞凋亡。 Transwell迁移和入侵测定用于确定细胞迁移能力和侵入能力。荧光素酶报告结果用于确定GC中DCST-AS1和MIR-605-3P的关系。结果:在本研究中,我们发现DCST1-AS1高表达,而MIR-605-3P在GC组织和细胞中表达低。此外,DCST1-AS1表达在GC中负调节miR-605-3p表达。功能性测试证明,DCST1的敲低抑制细胞增殖,迁移和侵袭以及GC细胞中的促进细胞凋亡。有趣的是,MiR-605-3P已被验证为DCST1-AS1的靶miRNA,其中荧光素酶报告结果测定。逆向实验确定了MiR-605-3P的抑制可以缓解低DCST1-AS1表达对GC中细胞生长的抑制作用。结论:我们首次证明了LNCRNA DCST1-AS1的监管网络,并探讨了,并发现LNCRNA DCST1-AS1调节细胞增殖,迁移,侵袭和凋亡,通过调节miR-605-3p,提供了一种新的治疗目标用于胃癌治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号